Summary
Axon Enterprise, Inc. reported strong top-line growth for the second quarter of 2021, with net sales increasing by 54.9% year-over-year to $218.8 million. This growth was driven by robust performance in both the TASER and Software & Sensors segments, with significant contributions from cartridge sales, the TASER 7 device, and expanded Axon Evidence and cloud services adoption. Despite the substantial revenue increase, the company reported a net loss of $47.1 million for the quarter, a wider loss compared to the prior year's $30.8 million. This was largely due to a significant increase in operating expenses, particularly stock-based compensation, which rose substantially due to updated estimates for performance-based awards. However, the company's financial position remains solid with $266.4 million in cash and cash equivalents and a strong overall contracted revenue backlog of $2.04 billion, indicating positive future revenue potential.
Financial Highlights
49 data points| Revenue | $218.79M |
| Cost of Revenue | $80.87M |
| Gross Profit | $137.93M |
| R&D Expenses | $53.95M |
| SG&A Expenses | $177.66M |
| Operating Expenses | $231.61M |
| Operating Income | -$93.69M |
| Net Income | -$47.12M |
| EPS (Basic) | $-0.72 |
| EPS (Diluted) | $-0.72 |
| Shares Outstanding (Basic) | 65.17M |
| Shares Outstanding (Diluted) | 65.17M |
Key Highlights
- 1Net sales surged by 54.9% year-over-year to $218.8 million, driven by strong demand across both TASER ($112.5M) and Software & Sensors ($106.3M) segments.
- 2TASER segment sales grew 59.6%, with significant increases in cartridge revenue (up 96.4%) and TASER 7 device sales (up 142.7%), indicating strong product adoption and replacement cycles.
- 3Software & Sensors segment sales increased 50.2%, fueled by the continued expansion of Axon Evidence and cloud services (up 44.1%) and robust sales of Axon Body cameras.
- 4Gross margin improved to 63.0% from 62.4% year-over-year, with notable margin expansion in the TASER segment (66.4% vs. 61.4%), reflecting manufacturing efficiencies and product mix.
- 5Operating expenses more than doubled, increasing to $231.6 million from $101.9 million, primarily due to a significant increase in stock-based compensation expenses related to performance awards.
- 6The company reported a net loss of $47.1 million for the quarter, compared to a net loss of $30.8 million in the prior year, despite strong revenue growth.
- 7Future contracted revenue stands at approximately $2.04 billion, providing strong visibility for future revenue recognition over the next five to seven years.